We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDHL
1326
Redhill Biopharma
RDHL
$3.68M
$14K ﹤0.01%
+17
New +$23.3K
VHC icon
1327
VirnetX Holding Corp
VHC
$63.1M
$14K ﹤0.01%
596
-3,880
-87% -$108K
WDH
1328
Waterdrop
WDH
$359M
$14K ﹤0.01%
10,732
-13,392
-56% -$17.7K
ABTC
1329
American Bitcoin Corp
ABTC
$471M
$11K ﹤0.01%
3
+1
+50% +$17.2K
AMBR
1330
Amber International Holding Ltd
AMBR
$130M
$11K ﹤0.01%
+1,613
New +$13.3K
HIPO icon
1331
Hippo Holdings
HIPO
$861M
$10K ﹤0.01%
+468
New +$17.3K
WTER
1332
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$10K ﹤0.01%
1,643
-160
-9% -$1.39K
SPRO icon
1333
Spero Therapeutics
SPRO
$73M
$8K ﹤0.01%
10,450
-15,466
-60% -$45K
DRRX
1334
DELISTED
DURECT Corp
DRRX
$7K ﹤0.01%
+1,534
New +$7.33K
EMBK
1335
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$6K ﹤0.01%
+558
New +$32.6K
KALA icon
1336
KALA BIO
KALA
$14.5M
$4K ﹤0.01%
5
-6
-55% -$9.41K
QTNT
1337
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3K ﹤0.01%
360
-650
-64% -$13.9K
MOHO
1338
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$2K ﹤0.01%
+11,668
New +$2.32K
AA icon
1339
Alcoa
AA
$13.2B
-4,580
Closed -$412K
AB icon
1340
AllianceBernstein
AB
$3.47B
-22,988
Closed -$1.08M
ACGL icon
1341
Arch Capital
ACGL
$33.6B
-6,610
Closed -$320K
ACI icon
1342
Albertsons Companies
ACI
$5.83B
-37,478
Closed -$1.25M
ACIW icon
1343
ACI Worldwide
ACIW
$5.46B
-16,250
Closed -$512K
ACMR icon
1344
ACM Research
ACMR
$5.79B
-12,678
Closed -$262K
ACM icon
1345
Aecom
ACM
$9.75B
-4,142
Closed -$318K
ACTG icon
1346
Acacia Research
ACTG
$470M
-26,629
Closed -$120K
ADAP
1347
DELISTED
Adaptimmune Therapeutics
ADAP
-69,612
Closed -$143K
ADI icon
1348
Analog Devices
ADI
$190B
-6,625
Closed -$1.09M
ADV icon
1349
Advantage Solutions
ADV
$361M
-549
Closed -$88K
ADVM
1350
DELISTED
Adverum Biotechnologies
ADVM
-39,559
Closed -$518K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.